Vaginal Estrogen Package Labeling: Time for a Change?

Dr. Allmen’s Comments:  It is time for a change regarding the labeling of Local Vaginal Estrogen.  Currently, local estrogen is lumped in with systemic estrogen compounds when it comes to labeling risk. That is just plain wrong.  The risks for systemic estrogen, although small for most women, are real.  There is, however, none of that risk when estrogen is used locally in the vagina to treat vaginal dryness, atrophy and painful intercourse.  The FDA may never go to the trouble of changing package labeling, but for those of you using local vaginal estrogen, I hope your mind is more at ease knowing that you have not put yourself in harm’s way, just in vaginal health’s way!

Tara Allmen, MD Credentials:
– Board Certified Gynecologist and Nationally Certified Menopause Practitioner
– New York City’s Leading Expert In Menopause
– President, North American Menopause Society Foundation
– Fellow of the American College of Obstetrics and Gynecology
– New York City’s Top Gynecologist, 2015
– Five Star Rating From Doctor’s Choice Awards
– Five Star Rating From HealthGrades